These effects, together with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 guidance the concept of targeting ACKR3 as a singular solution to modulate the opioid program, which could open up new therapeutic avenues for opioid-relevant disorders. Importantly, these receptors ended up https://mineru580snh7.yourkwikimage.com/user